Effects of thiazide-type and thiazide-like diuretics on cardiovascular events and mortality: Systematic review and meta-analysis

Hypertension

Volumn 65, Issue 5, 2015, Pages 1033-1040

  Engberink, Rik H G Olde ^a   Frenkel, Wijnanda J ^a   Van Den Bogaard, Bas ^a   Brewster, Lizzy M ^a   Vogt, Liffert ^a   Van Den Born, Bert Jan H ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

blood pressure; cardiovascular diseases; diuretics; heart failure; hypertension; thiazides

Indexed keywords

PLACEBO; THIAZIDE DIURETIC AGENT; THIAZIDE LIKE DIURETIC; THIAZIDE TYPE DIURETIC; UNCLASSIFIED DRUG;

ANTIHYPERTENSIVE ACTIVITY; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; COMPARATIVE EFFECTIVENESS; CORONARY ARTERY DISEASE; HEART FAILURE; HUMAN; HYPERTENSION; META ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK REDUCTION; SYSTEMATIC REVIEW; CARDIOVASCULAR DISEASES; DRUG EFFECTS; HEALTH; MORBIDITY; RISK FACTOR; TRENDS;

BLOOD PRESSURE; CARDIOVASCULAR DISEASES; GLOBAL HEALTH; HUMANS; MORBIDITY; RISK FACTORS; SODIUM CHLORIDE SYMPORTER INHIBITORS;

EID: 84930983889     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.114.05122     Document Type: Article

References (40)

1. IMS Institute for Healthcare Informatics. The use of medications in the United States: review 2011. http://www.environmentalhealthnews.org/ ehs/news/2013/pdf-links/IHII-Medicines-in-U.S-Report-2011-1.pdf. Accessed July 22, 2014
2. Mancia G, Fagard R, Narkiewicz K, et al; Task Force Members. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013; 31: 1281-1357. doi: 10.1097/01. hjh.0000431740.32696.cc.
3. James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014; 311: 507-520. doi: 10.1001/jama.2013.284427
4. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-Analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009; 338: b1665
5. Carter BL, Ernst ME, Cohen JD. Hydrochlorothiazide versus chlorthalidone: evidence supporting their interchangeability. Hypertension. 2004; 43: 4-9. doi: 10.1161/01.HYP.0000103632.19915.0E.
6. Ernst ME, Lund BC. Renewed interest in chlorthalidone: evidence from the Veterans Health Administration. Use of Diuretics in Patients with Hypertension. J Clin Hypertens. 2010; 12: 927-934. doi: 10.1111/j.1751-7176.2010.00373.x.
7. Ernst ME, Carter BL, Goerdt CJ, Steffensmeier JJ, Phillips BB, Zimmerman MB, Bergus GR. Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure. Hypertension. 2006; 47: 352-358. doi: 10.1161/01. HYP.0000203309.07140.d3
8. Woodman R, Brown C, Lockette W. Chlorthalidone decreases platelet aggregation and vascular permeability and promotes angiogenesis. Hypertension. 2010; 56: 463-470. doi: 10.1161/ HYPERTENSIONAHA.110.154476
9. Rendu F, Bachelot C, Molle D, Caen J, Guez D. Indapamide inhibits human platelet aggregation in vitro: comparison with hydrochlorothiazide. J Cardiovasc Pharmacol. 1993; 22(suppl 6): S57-S63
10. Dorsch MP, Gillespie BW, Erickson SR, Bleske BE, Weder AB. Chlorthalidone reduces cardiovascular events compared with hydrochlorothiazide: a retrospective cohort analysis. Hypertension. 2011; 57: 689-694. doi: 10.1161/HYPERTENSIONAHA.110.161505
11. Dhalla IA, Gomes T, Yao Z, Nagge J, Persaud N, Hellings C, Mamdani MM, Juurlink DN. Chlorthalidone versus hydrochlorothiazide for the treatment of hypertension in older adults: a population- based cohort study. Ann Intern Med. 2013; 158: 447-455. doi: 10.7326/0003-4819-158-6-201303190-00004
12. Roush GC, Holford TR, Guddati AK. Chlorthalidone compared with hydrochlorothiazide in reducing cardiovascular events: systematic review and network meta-Analyses. Hypertension. 2012; 59: 1110-1117. doi: 10.1161/HYPERTENSIONAHA.112.191106
13. Higgins JP, Green S. Cochrane Handbook for Systematic Reviews of Interventions. Chichester: Wiley; 2008
14. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-Analyses. BMJ. 2003; 327: 557-560. doi: 10.1136/ bmj.327.7414.557
15. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). JAMA. 2000; 283: 1967-1975
16. The Australian therapeutic trial in mild hypertension: Report by the Management Committee. Lancet. 1980; 1: 1261-1267. doi: 10.1016/ S0140-6736(80)91730-4
17. Amery A, Brixko P, Clement D et al. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial. Lancet. 1985; 1: 1349-1354
18. Kuramoto K, Matsushita S, Kuwajima I, Murakami M. Prospective study on the treatment of mild hypertension in the aged. Jpn Heart J. 1981; 22: 75-85
19. MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party. BMJ. 1985; 291: 97-104
20. Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party. BMJ. 1992; 304: 405-412
21. Smith WM. Treatment of mild hypertension: results of a ten-year intervention trial. Circ Res. 1977; 40: I98-105
22. Effects of treatment on morbidity in hypertension: results in patients with diastolic blood pressures averaging 115 through 129 mm Hg. JAMA. 1967; 202: 1028-1034. doi: 10.1001/jama.1967.03130240070013
23. Effects morbidity of treatment on in hypertension: II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg. JAMA. 1970; 213: 1143-1152. doi: 10.1001/jama.1970.03170330025003
24. Beckett NS, Peters R, Fletcher AE, et al; HYVET Study Group. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008; 358: 1887-1898. doi: 10.1056/NEJMoa0801369
25. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA. 1991; 265: 3255-3264. doi: 10.1001/jama.1991.03460240051027
26. Perry HM Jr, Smith WM, McDonald RH, Black D, Cutler JA, Furberg CD, Greenlick MR, Kuller LH, Schnaper HW, Schoenberger JA. Morbidity and mortality in the Systolic Hypertension in the Elderly Program (SHEP) pilot study. Stroke. 1989; 20: 4-13
27. Jamerson K, Weber MA, Bakris GL, Dahlöf B, Pitt B, Shi V, Hester A, Gupte J, Gatlin M, Velazquez EJ; ACCOMPLISH Trial Investigators. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med. 2008; 359: 2417-2428. doi: 10.1056/ NEJMoa0806182
28. Wing LM, Reid CM, Ryan P, Beilin LJ, Brown MA, Jennings GL, Johnston CI, McNeil JJ, Macdonald GJ, Marley JE, Morgan TO, West MJ; Second Australian National Blood Pressure Study Group. A comparison of outcomes with angiotensin-converting-enzyme inhibitors and diuretics for hypertension in the elderly. N Engl J Med. 2003; 348: 583-592. doi: 10.1056/NEJMoa021716
29. Berglund G, Andersson O. Beta-blockers or diuretics in hypertension?. A six year follow-up of blood pressure and metabolic side effects. Lancet. 1981; 1: 744-747
30. Wilhelmsen L, Berglund G, Elmfeldt D, Fitzsimons T, Holzgreve H, Hosie J, Hörnkvist PE, Pennert K, Tuomilehto J, Wedel H. Beta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trial. J Hypertens. 1987; 5: 561-572
31. Brown MJ, Palmer CR, Castaigne A, De Leeuw PW, Mancia G, Rosenthal T, Ruilope LM. Morbidity and mortality in patients randomised to double- blind treatment with a long-Acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT). Lancet. 2000; 356: 366-372. doi: 10.1016/S0140-6736(00)02527-7
32. Borhani NO, Mercuri M, Borhani PA, Buckalew VM, Canossa-Terris M, Carr AA, Kappagoda T, Rocco MV, Schnaper HW, Sowers JR, Bond MG. Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS). A randomized controlled trial. JAMA. 1996; 276: 785-791
33. Kuwajima I, Kuramoto K, Ogihara T, Iimura O, Abe K, Saruta T, Ishii M, Hiwada K, Fujishima M, Fukiyama K; National Intervention Cooperative Study in Elderly Hypertensives (NICS-EH) Study Group. Tolerability and safety of a calcium channel blocker in comparison with a diuretic in the treatment of elderly patients with hypertension: secondary analysis of the NICS-EH. Hypertens Res. 2001; 24: 475-480
34. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). JAMA. 2002; 288: 2981-2997
35. Malacco E, Mancia G, Rappelli A, Menotti A, Zuccaro MS, Coppini A; Shell Investigators. Treatment of isolated systolic hypertension: the SHELL study results. Blood Press. 2003; 12: 160-167
36. Rosei EA, Dal Palù C, Leonetti G, Magnani B, Pessina A, Zanchetti A. Clinical results of the Verapamil inHypertension and Atherosclerosis Study. VHAS Investigators. J Hypertens. 1997; 15: 1337-1344
37. Messerli FH, Makani H, Benjo A, Romero J, Alviar C, Bangalore S. Antihypertensive efficacy of hydrochlorothiazide as evaluated by ambulatory blood pressure monitoring: a meta-Analysis of randomized trials. J Am Coll Cardiol. 2011; 57: 590-600. doi: 10.1016/j.jacc.2010.07.053
38. Finkielman JD, Schwartz GL, Chapman AB, Boerwinkle E, Turner ST. Lack of agreement between office and ambulatory blood pressure responses to hydrochlorothiazide. Am J Hypertens. 2005; 18: 398-402. doi: 10.1016/j.amjhyper.2004.10.021
39. Ernst ME, Carter BL, Zheng S, Grimm Jr. RH Meta-Analysis of doseresponse characteristics of hydrochlorothiazide and chlorthalidone: effects on systolic blood pressure and potassium. Am J Hypertens. 2010; 23: 440-446. doi: 10.1038/ajh.2010.1
40. Van Blijderveen JC, Straus SM, Rodenburg EM, Zietse R, Stricker BH, Sturkenboom MC, Verhamme KM. Risk of hyponatremia with diuretics: chlorthalidone versus hydrochlorothiazide. Am J Med. 2014; 127: 763-771. doi: 10.1016/j.amjmed.2014.04.014